{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:26:16Z","timestamp":1761513976052,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.rdc.2016.12.007","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T02:00:29Z","timestamp":1489456829000},"page":"275-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Infertility \u2013 Prevention and Management"],"prefix":"10.1016","volume":"43","author":[{"given":"Emily C.","family":"Somers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Marder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.rdc.2016.12.007_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.007_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.38238","article-title":"Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan lupus epidemiology and surveillance program","volume":"66","author":"Somers","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.007_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40695-015-0012-9","article-title":"Rheumatic autoimmune diseases in women and midlife health","volume":"1","author":"Marder","year":"2015","journal-title":"Women\u2019s Midlife Heal"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.007_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.007_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/art.22683","article-title":"Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999","volume":"57","author":"Somers","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2016.12.007_bib6","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/rheumatology\/ker105","article-title":"Causes and management of infertility in systemic lupus erythematosus","volume":"50","author":"Hickman","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.007_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMcp0808697","article-title":"Clinical practice. Primary ovarian insufficiency","volume":"360","author":"Nelson","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.007_bib8","first-page":"604","article-title":"Incidence of premature ovarian failure","volume":"67","author":"Coulam","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.007_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2265.2007.03073.x","article-title":"Primary ovarian insufficiency: a more accurate term for premature ovarian failure","volume":"68","author":"Welt","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.rdc.2016.12.007_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1749-6632.2000.tb06251.x","article-title":"Premature ovarian failure is not premature menopause","volume":"900","author":"Kalantaridou","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.007_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0015-0282(97)81482-3","article-title":"Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors","volume":"68","author":"van Noord","year":"1997","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.007_bib12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/AOG.0b013e3181a66843","article-title":"Premature ovarian failure","volume":"113","author":"Rebar","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.007_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","article-title":"The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos","volume":"150","author":"Majumder","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9","key":"10.1016\/j.rdc.2016.12.007_bib14","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2008-0567","article-title":"Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition","volume":"93","author":"Sowers","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.007_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrendo.2011.224","article-title":"Anti-M\u00fcllerian hormone: an ovarian reserve marker in primary ovarian insufficiency","volume":"8","author":"Visser","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.007_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.rdc.2016.12.007_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/959487","article-title":"How much does AMH really vary in normal women?","volume":"2013","author":"La Marca","year":"2013","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.007_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.007_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.1.00529","article-title":"Anti-M\u00fcllerian hormone: a new marker for ovarian function","volume":"131","author":"Visser","year":"2006","journal-title":"Reproduction"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.007_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1191\/0961203302lu163oa","article-title":"Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations","volume":"11","author":"Pasoto","year":"2002","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.rdc.2016.12.007_bib21","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/rheumatology\/keu222","article-title":"Age at natural menopause among patients with systemic lupus erythematosus","volume":"53","author":"Alp\u00edzar-Rodr\u00edguez","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2016.12.007_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203315622824","article-title":"Prevalence of premature ovarian failure in patients with systemic lupus erythematosus","volume":"25","author":"Mayorga","year":"2016","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.rdc.2016.12.007_bib23","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/rheumatology\/kev124","article-title":"Ovarian reserve alterations in premenopausal women with chronic inflammatory rheumatic diseases: impact of rheumatoid arthritis, Beh\u00e7et\u2019s disease and spondyloarthritis on anti-M\u00fcllerian hormone levels","volume":"54","author":"Henes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"01","key":"10.1016\/j.rdc.2016.12.007_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4236\/arsci.2016.41003","article-title":"Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women before receiving cyclophosphamide therapy: evaluation using anti-M\u00fcllerian hormone","volume":"04","author":"Wei","year":"2016","journal-title":"Adv Reprod Sci"},{"issue":"9","key":"10.1016\/j.rdc.2016.12.007_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0961203314529468","article-title":"Ovarian reserve in women with primary antiphospholipid syndrome","volume":"23","author":"Yamakami","year":"2014","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.rdc.2016.12.007_bib26","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3899\/jrheum.131360","article-title":"Reduced ovarian reserve in patients with Takayasu arteritis","volume":"41","author":"Mont\u2019Alverne","year":"2014","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2016.12.007_bib27","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/0961203311409272","article-title":"Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone","volume":"20","author":"Lawrenz","year":"2011","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.007_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0961203315598246","article-title":"Assessment of anti-M\u00fcllerian hormone levels in premenopausal patients with systemic lupus erythematosus","volume":"25","author":"Gasparin","year":"2016","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.007_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0961203308094652","article-title":"Menstrual and hormonal alterations in juvenile systemic lupus erythematosus","volume":"18","author":"Medeiros","year":"2009","journal-title":"Lupus"},{"issue":"4\u20135","key":"10.1016\/j.rdc.2016.12.007_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2014.01.003","article-title":"Autoimmune primary ovarian insufficiency","volume":"13","author":"Silva","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.007_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/03009749109165287","article-title":"Counselling women with rheumatic disease\u2013how many children are desirable?","volume":"20","author":"Ostensen","year":"1991","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.007_bib32","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/rheumatology\/keq458","article-title":"Fertility in women with chronic inflammatory arthritides","volume":"50","author":"Wallenius","year":"2011","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.rdc.2016.12.007_bib33","first-page":"2310","article-title":"Number of births, interpregnancy interval, and subsequent pregnancy rate after a diagnosis of inflammatory rheumatic disease in Norwegian women","volume":"28","author":"Skomsvoll","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.007_bib34","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/acr.21593","article-title":"Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus","volume":"64","author":"Clowse","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.rdc.2016.12.007_bib35","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/art.24203","article-title":"Systemic lupus erythematosus in women: Impact on family size","volume":"59","author":"Vinet","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.007_bib36","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.30206","article-title":"Rheumatoid arthritis and pregnancy: beyond smaller and preterm babies","volume":"63","author":"Chakravarty","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.007_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/art.21859","article-title":"Childbearing decisions and family size among women with rheumatoid arthritis","volume":"55","author":"Katz","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2016.12.007_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/rheumatology\/XXVIII.suppl_1.33","article-title":"The relationship between rheumatoid arthritis and reproductive function","volume":"28","author":"Del Junco","year":"1989","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2016.12.007_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/msc.1031","article-title":"Navigating motherhood choices in the context of rheumatoid arthritis: women\u2019s stories","volume":"11","author":"Meade","year":"2013","journal-title":"Musculoskeletal Care"},{"issue":"7","key":"10.1016\/j.rdc.2016.12.007_bib40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.1780340714","article-title":"Pregnancy in patients with a history of juvenile rheumatoid arthritis","volume":"34","author":"Ostensen","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.007_bib41","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/art.30327","article-title":"Time to pregnancy among women with rheumatoid arthritis","volume":"63","author":"Jawaheer","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2016.12.007_bib42","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","article-title":"Fertility in women with rheumatoid arthritis: influence of disease activity and medication","volume":"74","author":"Brouwer","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.007_bib43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/humrep\/14.5.1250","article-title":"Regional differences in waiting time to pregnancy: pregnancy-based surveys from Denmark, France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group","volume":"14","author":"Juul","year":"1999","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.007_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12884-016-0919-7","article-title":"Reproductive trends in females with inflammatory joint disease","volume":"16","author":"Wallenius","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.007_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-2007-985612","article-title":"Advances in immunosuppressive therapy","volume":"28","author":"Marder","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"21","key":"10.1016\/j.rdc.2016.12.007_bib46","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.007_bib47","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.rdc.2016.12.007_bib48","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.007_bib49","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","article-title":"The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.007_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.007_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/096120399678847335","article-title":"Preserving ovarian function in patients receiving cyclophosphamide","volume":"8","author":"Slater","year":"1999","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.rdc.2016.12.007_bib52","first-page":"1660","article-title":"Effect of cyclophosphamide on the immature rat ovary","volume":"49","author":"Ataya","year":"1989","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.rdc.2016.12.007_bib53","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM197311292892202","article-title":"Cyclophosphamide-induced ovarian failure","volume":"289","author":"Warne","year":"1973","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.007_bib54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/jwh.2008.0857","article-title":"Ovarian preservation by GnRH Agonists during chemotherapy: a meta-analysis","volume":"18","author":"Clowse","year":"2009","journal-title":"J\u00a0Womens Health"},{"issue":"8","key":"10.1016\/j.rdc.2016.12.007_bib55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1191\/0961203304lu1063oa","article-title":"Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy","volume":"13","author":"Park","year":"2004","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.007_bib56","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ard.55.4.224","article-title":"Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide","volume":"55","author":"McDermott","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.007_bib57","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","article-title":"Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.rdc.2016.12.007_bib58","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/1529-0131(199805)41:5<831::AID-ART9>3.0.CO;2-1","article-title":"Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy","volume":"41","author":"Mok","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2016.12.007_bib59","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/acr.20605","article-title":"Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener\u2019s)","volume":"63","author":"Clowse","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.rdc.2016.12.007_bib60","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.fertnstert.2004.07.925","article-title":"Ovarian tissue and oocyte cryopreservation","volume":"82","author":"ASRM\/ART PC","year":"2004","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.rdc.2016.12.007_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.fertnstert.2012.09.028","article-title":"Mature oocyte cryopreservation: a guideline","volume":"99","author":"ASRM\/ART PC","year":"2013","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.rdc.2016.12.007_bib62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","article-title":"Ovulation induction and in\u00a0vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome","volume":"43","author":"Guballa","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2016.12.007_bib63","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2011-03-340216","article-title":"Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis","volume":"118","author":"Di Nisio","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.007_bib64","first-page":"1192","article-title":"Association of common thrombophilias and antiphospholipid antibodies with success rate of in\u00a0vitro fertilisation","volume":"108","author":"Steinvil","year":"2012","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.rdc.2016.12.007_bib65","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1177\/0961203314527370","article-title":"Assisted reproductive technology in SLE and APS","volume":"23","author":"Levine","year":"2014","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.rdc.2016.12.007_bib66","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/0961203314529171","article-title":"Antiphospholipid antibodies and infertility","volume":"23","author":"Chighizola","year":"2014","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.rdc.2016.12.007_bib67","first-page":"9","article-title":"Ovarian damage during chemotherapy in autoimmune diseases: broad health implications beyond fertility","volume":"2012","author":"Marder","year":"2012","journal-title":"Clin Med Insights Reprod Health"},{"key":"10.1016\/j.rdc.2016.12.007_bib68","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","article-title":"Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"Somers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2016.12.007_bib69","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/09513590.2011.650752","article-title":"Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients","volume":"28","author":"Marder","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"10.1016\/j.rdc.2016.12.007_bib70","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/14656566.2015.1031654","article-title":"Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists","volume":"16","author":"Blumenfeld","year":"2015","journal-title":"Expert Opin Pharmacother"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16301107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16301107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:16:27Z","timestamp":1760181387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X16301107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0889857X16301107"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2016.12.007","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infertility \u2013 Prevention and Management","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}